ZUG, Switzerland, Aug. 29, 2024 (GLOBE NEWSWIRE) — Oculis Holding AG (Nasdaq: OCS) (“Oculis”), a global biopharmaceutical company purposefully driven […]
ATLANTA, GA, Aug. 28, 2024 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing immunotherapies and […]